Image SmartCT Soft Tissue Neuro
Image-guided therapy

Ischemic stroke treatment

Be ready to take on new challenges in ischemic stroke treatment with these innovative approaches

We see a strong increase in thrombectomy interventions as a first-line treatment for patients with ischemic stroke.1 There is also a shift from time-based to image-based selection in this area. Our neurovascular suite has been developed to help to address these trends. It can support high levels of procedural efficiency and redefine outcomes for your stroke patients as you decide, guide, treat and confirm.

SmartCT in stroke

The next leap in simplifying and advancing 3D imaging

Perform differential stroke diagnosis right in the neuro suite with step-by-step user guided set-up of cone-beam CT, fast high-quality CBCT protocols and full control of 3D volume at table side.

Demonstrated results in ischemic stroke treatment

  1. 65%

    reduction in patient dose in interventional neuro procedures2​

    65%

    reduction in patient dose in interventional neuro procedures2​

    with ClarityIQ compared to a system without ClarityIQ

  2. 88%

    of users believe they can have more focus on their patient

    88%

    of users believe they can have more focus on their patient

    thanks to full tableside control with the touchscreen module4

  3. 39

    cm (15 in) lateral detector

    39

    cm (15 in) lateral detector

    of Azurion can be positioned close to the patient’s head while providing full brain coverage.

Workflow innovations to help on-call staff work efficiently and easily, maintaining a patient focus

There are two important drivers for successful stroke treatment: time to treatment and image quality during treatment. Philips is innovating in both areas to support clinicians in obtaining the best patient outcomes. Direct to Angio suite workflows allow for comprehensive stroke diagnosis to be performed directly in the neuro angio suite. This provides valuable timesaving support for critical patients in acute need of mechanical thrombectomy therapy.1

Comprehensive diagnosis and treatment for ischemic stroke

  • See more during neurovascular interventions and elevate treatment confidence with excellent visibility at very low X-ray dose levels
  • Integrated biplane systems put you in firm control from a single touchscreen at tableside to enhance decision-making and run an entire case without breaking sterility
  • Provides simplified 3D visualization and measurements at tableside to help improve treatment outcomes
  • Creates the ideal treatment environment with specific tools and workflows for multiple clinical specialties in one room

Improved flexibility and speed in treating ischemic stroke

  • SmartCT Soft Tissue (CT-like visualization) for comprehensive stroke diagnosis and peri-procedure check of bleeds
  • Dual View to see collateral filling
  • SmartCT Vaso to check clot length and location
  • 2D DSA with ClarityIQ maintains sharp images
  • Roadmap Pro provides enhanced visualization of vasculature
  • DSA run-off helps confirm treatment success

Image gallery

  • SmartCT Soft Tissue
    Create CT-like visualization with SmartCT Soft Tissue-Generate a CT-like visualization of soft tissue, supporting stroke diagnosis
  • SmartCT Vaso
    Check location and length of a clot with SmartCT Vaso-Allow visualization beyond the clot with peri-procedural imaging of the distal vessel aspects in ischemic stroke
  • Dual View
    See collateral filling with Dual View-View early- and late-phase CBCT volumes side by side to enhance identification of penumbra and enable visualization of collateral filling
  • SmartCT Soft Tissue (CT-like)
    Peri-procedure check of bleeds with SmartCT Soft Tissue-Use these CT-like images in the neurovascular suite to check treatment success and bleeds
  • 2D-DSA-ClarityIQ
    See sharp images with 2D DSA with ClarityIQ technology-Help maintain sharp images of the vessels with automatic motion compensation during real-time DSA
  • SmartCT Roadmap
    Support precise 3D navigation with the anatomical references of SmartCT Roadmap-Use anatomical references to support precise navigation of guidewire, catheter and device to the clot
  • DSA Run off
    Confirm treatment success with high-quality DSA visualization-Assess if the complete clot has been retrieved and if pieces of the clot have been dispersed distally in the brain
  • Roadmap Pro
    Enhance visualization of vasculature with Roadmap Pro-Use this advanced double-contrast roadmap to help enhance visualization of overlapping vessels, while balancing radiation exposure

I always say to the young doctors: If you don’t see, then you don’t understand, and if you don’t understand, you cannot treat. And 3D is the key tool.

Professor. Laurent Spelle
Chef de Service
NEURI Bicêtre, Paris, France
Customer testimonial Paris Bicetre, experiences with Azurion and SmartCT

Enabling technologies

  • Two clinicians viewing screens using ClarityIQ during interventional procedure.

    ClarityIQ technology delivers significantly lower dose across the clinical area, patients, and operators.

Related procedures

  • Cerebral aneurysm treatment

    Optimize cerebral aneurysm treatment with imaging solutions for precise device placement, effective workflows, and superior 2D and 3D visualization.

  • AVM Treatment thumbnail

    See how Philips helps provide neurovascular care with precise interventions for arteriovenous malformations (AVMs) and arteriovenous fistulas (AVFs).

Documentation

Neuro Suite – Neuro decisions are based on what you see, so see more
PDF|(920.23 KB)
Footnotes
  1. www.mdedge.com/neurology/article/107506/stroke/stroke-centers-increase-and-refine-use-thrombectomy
  2. Söderman, M., et al., Radiation dose in neuro angiography using image noise reduction technology: a population study based on 614 patients. Neuroradiology, 2013. 55(11): p. 1365-1372. ​ Routine neuro interventions comprise of DSA and fluoroscopy usage. (95% CI 56%, 68% for routine diagnostic neuro endovascular procedures, 95% CI 58%, 71% for routine interventional neuro endovascular procedures). The results of the application of dose reduction techniques will vary depending on the clinical task, patient size, anatomical location and clinical practice. The interventional radiologist assisted by a physicist as necessary has to determine the appropriate settings for each specific clinical task. Results based on total dose area product from a single center retrospective historically controlled cohort study (Karolinska Hospital - Solna, Sweden) on 614patients (302 for Allura Xper and 312 for AlluraClarity) undergoing neuro endovascular procedures.
  3. Market Research Group reports ‘16-’17.
  4. The user level of expertise required is described in the Instructions for Use as the Intended Operator Profile.
  5. 3D reconstructions at higher resolution settings may take longer times.
Disclaimer
Product availability is subject to country regulatory clearance. Please contact your local sales representative to check the availability in your country.